D. Adu

4.0k total citations · 1 hit paper
58 papers, 2.9k citations indexed

About

D. Adu is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Rheumatology. According to data from OpenAlex, D. Adu has authored 58 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 17 papers in Nephrology and 12 papers in Rheumatology. Recurrent topics in D. Adu's work include Vasculitis and related conditions (16 papers), Renal Diseases and Glomerulopathies (14 papers) and Renal Transplantation Outcomes and Treatments (9 papers). D. Adu is often cited by papers focused on Vasculitis and related conditions (16 papers), Renal Diseases and Glomerulopathies (14 papers) and Renal Transplantation Outcomes and Treatments (9 papers). D. Adu collaborates with scholars based in United Kingdom, Ghana and United States. D. Adu's co-authors include Caroline O.S. Savage, P A Bacon, P. Emery, Raashid Luqmani, Abeed A. Pall, B Janssen, Robert J. Moots, Nicholas T. Richards, Lorraine Harper and J. Michael and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Kidney International.

In The Last Decade

D. Adu

57 papers receiving 2.8k citations

Hit Papers

Birmingham Vasculitis Activity Score (BVAS) in systemic n... 1994 2026 2004 2015 1994 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Adu United Kingdom 26 1.8k 869 709 534 525 58 2.9k
Dwomoa Adu United Kingdom 30 1.4k 0.8× 662 0.8× 1.3k 1.8× 515 1.0× 415 0.8× 73 3.2k
Jan‐Stephan Sanders Netherlands 34 1.2k 0.7× 430 0.5× 455 0.6× 875 1.6× 270 0.5× 168 4.2k
Stephen P. McAdoo United Kingdom 27 1.0k 0.6× 474 0.5× 711 1.0× 643 1.2× 192 0.4× 103 2.5k
Andrew Exley United Kingdom 23 1.2k 0.7× 596 0.7× 119 0.2× 634 1.2× 352 0.7× 46 2.3k
Alexandre Karras France 40 1.2k 0.7× 880 1.0× 2.0k 2.8× 1.3k 2.5× 245 0.5× 164 5.1k
Christopher G. Winearls United Kingdom 30 735 0.4× 225 0.3× 1.1k 1.6× 193 0.4× 239 0.5× 83 3.6k
Conrad L. Pirani United States 34 569 0.3× 1.2k 1.4× 1.6k 2.2× 557 1.0× 112 0.2× 79 3.1k
Yoshifumi Ubara Japan 29 826 0.5× 616 0.7× 1.5k 2.1× 210 0.4× 293 0.6× 366 3.6k
E Imbasciati Italy 28 602 0.3× 543 0.6× 1.8k 2.6× 481 0.9× 75 0.1× 94 2.9k
Nesrin Beşbaş Türkiye 32 668 0.4× 519 0.6× 1.1k 1.6× 1.2k 2.3× 154 0.3× 169 3.6k

Countries citing papers authored by D. Adu

Since Specialization
Citations

This map shows the geographic impact of D. Adu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Adu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Adu more than expected).

Fields of papers citing papers by D. Adu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Adu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Adu. The network helps show where D. Adu may publish in the future.

Co-authorship network of co-authors of D. Adu

This figure shows the co-authorship network connecting the top 25 collaborators of D. Adu. A scholar is included among the top collaborators of D. Adu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Adu. D. Adu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ojo, Akinlolu, D. Adu, Kate Bramham, et al.. (2025). APOL1 kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International. 108(5). 763–779. 2 indexed citations
3.
Pankhurst, Tanya & D. Adu. (2004). Antibodies in the prevention of renal allograft rejection. Expert Opinion on Biological Therapy. 4(2). 243–252. 4 indexed citations
4.
Adu, D., et al.. (2003). Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials. BMJ. 326(7393). 789–789. 118 indexed citations
5.
Cockwell, Paul, Christopher Brooks, D. Adu, & Caroline O.S. Savage. (1999). Interleukin-8: A pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. Kidney International. 55(3). 852–863. 118 indexed citations
6.
Harper, Lorraine, et al.. (1998). Vasculitis Sistémica Primaria. SHILAP Revista de lepidopterología.
7.
Harper, Lorraine, et al.. (1997). Primary systemic vasculitis. The Lancet. 349(9051). 553–558. 152 indexed citations
8.
Yeboah, Edward D., et al.. (1996). Hemodialysis in the Treatment of Acute Renal Failure in Tropical Africa: A 20-Year Review at the Korle Bu Teaching Hospital, Accra. Renal Failure. 18(3). 517–524. 11 indexed citations
9.
Adu, D., Caroline O.S. Savage, C M Lockwood, et al.. (1994). ANCA POSITIVE AND ANCA NEGATIVE MICROSCOPIC POLYARTERITIS. Journal of the American Society of Nephrology. 5(3). 825–825. 4 indexed citations
10.
Luqmani, Raashid, Abeed A. Pall, D. Adu, et al.. (1993). CONTROLLED TRIAL OF PULSE VS CONTINUOUS CYCLOPHOSPHAMIDE (CY) AND PREDNISOLONE (P) IN THE TREATMENT OF SYSTEMIC VASCULITIS. Oxford University Research Archive (ORA) (University of Oxford). 36. 1 indexed citations
11.
Gordon, Melita A., Raashid Luqmani, D. Adu, et al.. (1993). Necrotizing Vasculitis — Relapse Despite Cytotoxic Therapy. Advances in experimental medicine and biology. 336. 477–481. 9 indexed citations
12.
Adu, D., Alexander J. Howie, P. Emery, et al.. (1993). GLOMERULONEPHRITIS IN RHEUMATOID ARTHRITIS. Lara D. Veeken. 32(11). 1008–1011. 18 indexed citations
13.
Varagunam, Mira, et al.. (1993). Little Evidence for Anti-Endothelial-Cell Antibodies in Microscopic Polyarteritis and Wegener’s Granulomatosis. Advances in experimental medicine and biology. 336(2). 419–422. 14 indexed citations
14.
Richards, Nicholas T., et al.. (1993). Increased prevalence of dialysis-dependent renal failure in ethnic minorities in the West Midlands. Nephrology Dialysis Transplantation. 8(2). 146–148. 16 indexed citations
15.
Greaves, Ian, K F Kane, Nicholas T. Richards, et al.. (1992). Pigeons and peritonitis?. Nephrology Dialysis Transplantation. 7(9). 967–969. 21 indexed citations
16.
Beaman, M., I. C. M. Maclennan, & D. Adu. (1989). T-Cell-Independent and T-Cell-Dependent Antibody Responses in Patients with Chronic Renal Failure. Nephrology Dialysis Transplantation. 4(3). 216–221. 31 indexed citations
17.
Brown, Phillip, et al.. (1985). Peritonitis due to Streptococcus viridans in patients receiving continuous ambulatory peritoneal dialysis.. BMJ. 290(6473). 969.2–970. 20 indexed citations
18.
McMaster, P, et al.. (1984). Combined kidney and pancreas grafting--is it really safe and does it jeopardize the kidney?. PubMed. 16(3). 704–6. 4 indexed citations
19.
Brown, Christian, J S Cameron, D. Adu, et al.. (1983). High versus "low" dose corticosteroids in recipients of cadaveric kidneys: prospective controlled trial.. BMJ. 286(6371). 1097–1100. 18 indexed citations
20.
Adu, D., et al.. (1973). Renal transplantation in leprosy.. BMJ. 2(5861). 280–281. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026